The use of directed evolution to create a stable and immunogenic recombinant BCG expressing a modified HIV-1 Gag antigen.

Numerous features make Mycobacterium bovis BCG an attractive vaccine vector for HIV. It has a good safety profile, it elicits long-lasting cellular immune responses and in addition manufacturing costs are affordable. Despite these advantages it is often difficult to express viral antigens in BCG, wh...

詳細記述

書誌詳細

主要な著者:	Rosamund Chapman, William R Bourn, Enid Shephard, Helen Stutz, Nicola Douglass, Thandi Mgwebi, Ann Meyers, Nyasha Chin'ombe, Anna-Lise Williamson
フォーマット:	Artigo
言語:	Inglês
出版事項:	Public Library of Science (PLoS) 2014-01-01
シリーズ:	PLoS ONE
オンライン･アクセス:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25061753/pdf/?tool=EBI
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!